NCT05026125View on ClinicalTrials.gov

Quality Assessment of Orotracheal Intubation Without Neuromuscular Blocking Agents in Obese Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 13, 2022

Primary Completion Date

August 11, 2023

Study Completion Date

August 11, 2023

Conditions
ObesityBariatric Surgery CandidateIntubation Complication
Interventions
DRUG

Remifentanil Injection

Injection of 3 μg/kg (Ideal Body Weight) of Remifentanil in the induction phase of anesthesia for orotracheal intubation for bariatric surgery

DRUG

Remifentanil Injection plus 30%

Injection of 3 μg/kg (Ideal Body Weight) plus 30% of Remifentanil in the induction phase of anesthesia for orotracheal intubation for bariatric surgery

Trial Locations (1)

Unknown

Hospital University of Toulouse, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER